{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:29:01Z","timestamp":1785472141117,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1053\/j.ackd.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T20:34:05Z","timestamp":1507926845000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of Abnormalities of Potassium Homeostasis in CKD"],"prefix":"10.1053","volume":"24","author":[{"given":"Biff F.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ackd.2017.06.001_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1152\/advan.00121.2016","article-title":"Physiology and pathophysiology of potassium homeostasis","volume":"40","author":"Palmer","year":"2016","journal-title":"Adv Physiol Educ"},{"issue":"6","key":"10.1053\/j.ackd.2017.06.001_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Renal physiology: regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2017.06.001_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/j.2040-4603.2015.tb00597.x","article-title":"Distal convoluted tubule","volume":"5","author":"McCormick","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1053\/j.ackd.2017.06.001_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-physiol-021115-105431","article-title":"Regulation of renal electrolyte transport by WNK and SPAK-OSR1 kinases","volume":"78","author":"Hadchouel","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10.1053\/j.ackd.2017.06.001_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI109540","article-title":"Functional profile of the isolated uremic nephron: potassium adaptation in the rabbit cortical collecting tubule","volume":"64","author":"Fine","year":"1979","journal-title":"J Clin Invest"},{"issue":"5 Pt 2","key":"10.1053\/j.ackd.2017.06.001_bib6","first-page":"R989","article-title":"Renal potassium transport: morphological and functional adaptations","volume":"257","author":"Stanton","year":"1989","journal-title":"Am J Physiol"},{"issue":"8","key":"10.1053\/j.ackd.2017.06.001_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2215\/CJN.06060612","article-title":"Hyperkalemia in pre-dialysis patients","volume":"7","author":"Palmer","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"10.1053\/j.ackd.2017.06.001_bib8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.ackd.2017.06.001_bib9","unstructured":"National Institute for Health Care Excellence (NICE). Chronic kidney disease in adults: assessment and management. Clin guideline (cg182) Published July 23, 2014. Last updated January 2015. http:\/\/www.nice.org.uk\/guidance\/cg182. Accessed October 5,\u00a02016."},{"issue":"14","key":"10.1053\/j.ackd.2017.06.001_bib10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"issue":"5 suppl 1","key":"10.1053\/j.ackd.2017.06.001_bib11","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ackd.2017.06.001_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic","volume":"7","author":"Sarafidis","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2017.06.001_bib13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2215\/CJN.06290616","article-title":"The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals","volume":"12","author":"Hughes-Austin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11 suppl","key":"10.1053\/j.ackd.2017.06.001_bib15","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.ackd.2017.06.001_bib16","unstructured":"Latts LM, Reaven NL, Funk SE, et\u00a0al. Hyperkalemia in patients with cardiorenal comorbidities. Poster presented at: ISPOR 20th Annual International Meeting; May 16-20, 2015; Philadelphia, PA. https:\/\/www.ispor.org\/research_pdfs\/49\/pdffiles\/PCV33.pdf. Accessed January 13,\u00a02017."},{"issue":"3","key":"10.1053\/j.ackd.2017.06.001_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semnephrol.2014.04.008","article-title":"Prediction and management of hyperkalemia across the spectrum of chronic kidney disease","volume":"34","author":"Lazich","year":"2014","journal-title":"Semin Nephrol"},{"issue":"21","key":"10.1053\/j.ackd.2017.06.001_bib18","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia. The HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1053\/j.ackd.2017.06.001_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2017.06.001_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diaclin.34.1.3","article-title":"Standards of medical care in diabetes\u20142016 abridged for primary care providers","volume":"34","year":"2016","journal-title":"Clin Diabetes"},{"issue":"5","key":"10.1053\/j.ackd.2017.06.001_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"J Am Med Assoc"},{"issue":"10","key":"10.1053\/j.ackd.2017.06.001_bib22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1046\/j.1532-5415.2002.50457.x","article-title":"Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications","volume":"50","author":"Ahmed","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1053\/j.ackd.2017.06.001_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the\u00a0renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.ajkd.2010.01.020","article-title":"A physiologic based approach to the evaluation of a patient with hyperkalemia","volume":"56","author":"Palmer","year":"2010","journal-title":"Am J Kidney Ds"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI108107","article-title":"NaHCO3 and NaC1 tolerance in chronic renal failure","volume":"56","author":"Husted","year":"1975","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2017.06.001_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pds.1217","article-title":"Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers","volume":"16","author":"Raebel","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1062860605285047","article-title":"Follow-up of markedly elevated serum potassium results in the ambulatory setting: implications for patient safety","volume":"21","author":"Moore","year":"2006","journal-title":"Am J Med Qual"},{"issue":"5","key":"10.1053\/j.ackd.2017.06.001_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2017.06.001_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0016-5085(95)90448-4","article-title":"Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion","volume":"108","author":"Emmett","year":"1995","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1053\/j.ackd.2017.06.001_bib31","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2215\/CJN.03640415","article-title":"Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD","volume":"10","author":"Lepage","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2017.06.001_bib32","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01170216","article-title":"Effect of patiromer on urinary ion excretion in healthy adults","volume":"11","author":"Bushinsky","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2017.06.001_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000451067","article-title":"Patiromer decreases serum potassium and phosphate levels in patients on hemodialysis","volume":"44","author":"Bushinsky","year":"2016","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2017.06.001_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2017.06.001_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease. The AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1053\/j.ackd.2017.06.001_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ackd.2017.06.001_bib37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1053\/j.ackd.2017.06.001_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.mayocp.2016.01.012","article-title":"Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity","volume":"91","author":"Palmer","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1053\/j.ackd.2017.06.001_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005792-198109000-00002","article-title":"Internal potassium balance and the control of the plasma potassium concentration","volume":"60","author":"Sterns","year":"1981","journal-title":"Medicine"},{"issue":"6","key":"10.1053\/j.ackd.2017.06.001_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/j.ajkd.2010.07.010","article-title":"A physiologic-based approach to the evaluation of a patient with hypokalemia","volume":"56","author":"Palmer","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2017.06.001_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semnephrol.2011.09.009","article-title":"Metabolic complications associated with use of diuretics","volume":"31","author":"Palmer","year":"2011","journal-title":"Semin Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559517300897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559517300897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:00:56Z","timestamp":1761548456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559517300897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1548559517300897"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2017.06.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Abnormalities of Potassium Homeostasis in CKD","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}